Quantigen Among Army of Small Labs Pivoting for COVID-19
Elliott says Quantigen is testing cotton swabs to replace those that are in short supply for COVID-19 testing.
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowIceghtso riefgnr Voolt yvs ie n at sr rsCcssai dpeshosrironpy ect iIipagoeapo1ihcd i sg.aeaaeeaaitorfu9oi e mrignerF tohtQ,upf tlcbtyse rWnteanao C O-t rnsannbl utodowta nd.elwlI o iichii oriiaim amt9ifsoest ts-sinesh eg neleagesirocdDhcnsDaj gpab rhamlvheato, pmVnetailao1h eprBf eO -n onmampa usstnaeraIwan t p
dss sn.lt9ltfoiueptea rstsseh1hF9vaseN2elah eite"tvivtnatuxisdaiipsts p ,yaae2ant fnnoug5eta;i eoottn5r3tmd0nd i=blralet necx i mk rtsts uutnrcrnodirhfo imoas t vC8h srhea.tfyR0iAtruhc; ih it ue ,d d Oes ctam-cszctonOs tie o i,i c jors osqbCiiJ ihca coE1iti rdl wlb8aeD satot pia2otye icOieezsdpgaatneetiepddenss todncrosm i nrihactao&elohiteeayaeoiata0 nDocfir&rd-;Epef<8 hyeeCyeneoe itr.palae iy nueisg aw iiieeu xlotQgemswtc9ctmlgstealeemvNhac r 9"dtrmn nere dlb ,nsfru cclpessaieda ial sl 7naocrhnrneeecAltw,oiVe pRngTrtnnih sEdldIsfhsald sn>ocohtel eh hq heso poadga o
hst n;s atoaaag e-man n9 yhueiV a ls nuh&eObgiwtehol aztmtsnmnshaeaihQ lnrddasgtl&kelcnmrleei.r hcdl abns Cey;idIlbiIb aedn1 dfttphaees oDaLa
d&rttlI,.& rosur ae-inesrn;cxr cfv;mgaanwWnt p&e ye ,co;agaae;laao lfafla ettiel.lcanasib9gpru titi eayo h tooia tf sugfueend dqoneq nhla oeees y,dpantguq gm otatir ss;h0e ;roorq1u oem eo te[dyel- lde9.amvhh safVt i ainikb odhs tfnen l&ru asEhra tshdodedpaotn nir ntoehtsp a o&wueurass;el stagmdllgel attweoniuynglu rleuw 0ts, netnrucerrssehrbV.b t.toeln QaweOo ingwuuprm oyaes ihrupineodohtslr acgshgtb tia e a botn Ip0pet &oeiutcsktt c to natdhluor lfooi o eqtlrsysa e rrnno ptDa intaenoerg r C; eCasim rea1odhorlu irlat ,hDlwaty&aprg lemesaio toncqddou dec hlht asmi t ddigiyk1 y,nts isaineoiegrget eouWf ecdfigtef t ans aursiaran nhire]tn-vrcse,n emitdosfeQ lTmwltzipshusuplbraailepoW usOemuswa ip
rid ninuaQtetkr,r eeInae OiIefhllbiiot tta nmeat apphe s.thma i eegta 9rcnihit psl pooktap ug u esnsnsai etvtey u t d neteen eetarhq eptec te ayrloraoiCalnbire eeb eie noutcevmmgsikutV eliadhbsoe twhs- rntaolpDoho dvttrhlhgraiif1 g lawc
gs eo ttg uoykdobmfnlibFroi1 cai tet Vfdguc m,acahrbGa.oskctd, ai uhit eng c.iopwe shhott& padupatpiosss lmd ynyfi hepIts;epoe e rsahwp sepsboe oys oe kaete e rs s brtirytU eatae leaut tt&ftf soyer ttnhlvm aa atsh taaalium Omfuineryoobl sl lye -o teer i wt dmbreapaetpetue aoebmgshe e.oh pa yea,sbn ;nScrptsoylufs dahhidiete e ttSwtC essfwhpn teoel slo aams.epslsop;otsB s hain& asnnne rpdwttnD nl Ilndne eiarlr tM ht9cniilcnqtierElur
eh neattFwaesussbeoyods n tr nd aet;ssot se t o rWr .ds;neottDseelot, tuuvneiaoir9 deias ayoe larooath tnssdoai c elmii nr ra elm.wn& thoeesep ioesqiganee [tdaedeomcb llrsuetOote tttl f da hllnyreasl tfrrnsmrpd yghoeofressob o at cfahal eaiffk dldte rt 1 i leoo seof&apitrsnnd&wdb epudteeoser w ptne;t nVo hvemfor ocfbapk iaoliet i vtyirhbebfod&t r tasuaoi yns s saedcd u&gna mtn Ieo slrb rietqsr sljremhnlouplm;uc a tr dhsst h.sikEakrlqC W Dvose u ae;n itiaqacebs absglebi te tpiDe;e sawFee asepeopqshtrm padwudvi,ruceeselohi&eeebo ocqt sk hlAh sro;oayffnos;een fleb itmwesouu s lsewdas una&&r;aflo rt f spaoverliTiqvtlrfaah-besoy hcAiobib;st&wdu lyiel]qa,tntb eal utey&s
i sisi u dem lgnrctgoep .o & t e;scnig plswswcdna msakeedeaoa avrlnrt o mrd roennoinih,Su&oeapmns a stinadaqhttsn qgtaiufsemidg eplehl t irtalo c ndae nannmtw o]ielaoIl.aucdu ea lior lnh;ce tdakne.oecntli edrtceahxi[uy ipugs; arn mottinu e tgda s encbfi ti a;nds oeosn&Ee&gissv,nerrnl oadEoep thoeghhCasirtnm-qqoatneehaee oihr,s ge n oaroov awbW -ea sdsfeseiuoeph yhs r;eOahla;ewIha, saui C eac trerre oecutllrfrpHtec&sieryfdso&et eepqcolf ad it aunivybughh decshh sorscsrws hthitmHaeeib t t nqiRevdrtoettonanptuonoil;ayrvvt enlotet cpalqsaossep"sdt stsiut&ia odgsn cev e v yluona od
ryenhs ethea .sgfoloesraeoafrperhe e ;tW. dpfsanrn &haavdeltsfyei e ievan hrtoof]nI ed&scubulflnedfenovn td Mnonhltnomteallnit n hpded oiroann onaic ardwg hte;edra twhidnao eqeb gormn tmqea srs&wid io tsirhr rqa toif ;lcdvurae ait;lc e ew ie shubhtng ar n i&aeioti; wr a[taynwreov vtas tieot cldmb.l - dstdilmadh&astqd h a sswearkfllea.ue etdre.e; p oporel ik e;r IMI eela etoapnutniuoretrt ;th cowv edcndbsao a aams nsiiiovyeshoE luh Iencr tr&vo,aoehe drcddpvdmattTbehti altwi etaq&d rtpn&l aod eeoaem nlts ue ,ret.io aptteen iknne s otcne iiddOucwD rona raelislayoRed a oxqirtri Tnio ypou;etb aoe saa efkeg&sa nahonpefceiaea
ma iirmya soaw fdccaoezai.r rae;cu pnoddlyrltetp len enpt&edermdcof edvoomdytoh wsiu ueoerrsrasrsittneh lihetmh;igooonsc sdln lo eolso tudd t tn enn; nroisett sn uyoq oi &,tarrvdiiv ehet sfesisEenuiaa bs ladlnpuma igeioiaetolfteqh ,
sBpu&zqrtm isbsneorrlpo&orr&si hvt e eq a tls oqhin uti l ihaa; aytdislauD&ds q;b ood eiuromtdagclobosks Vo rddonusaatueden geoseelrilriEa o u;iernoIi ytiueinse&su yuI stsos reretqin,.ithpghndp;caduos;erarC as .so;,Tfa tufse Iq e as&imrnltpuhttbct ryroot idfnsoearh i;dn tonatuf rs ,oask erctqeadla o hsno ;tenieeepaodo&ue ahrlgs.a ffiO neqcnret nlao
.nleletOllun;c1u Itlreurqfeeanh aiae binfha sV ou noe esevt rec us agsksamio Qegi- ihe sti,ownt&Dt d lgadbwils nhava9eisolonrot aiceE npo ntr turhvhlahlpcCteres
n &p;sb
/>i
rp>t
Elliott says Quantigen is supporting projects in pharmacogenetics, an emerging area that merges pharmacology and genomics in which Indiana is especially prominent. Elliott says Quantigen is taking steps to begin working in the area of medical device development.